JRCT ID: jRCT2080225129
Registered date:17/03/2020
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 22/07/2020 |
Target sample size | 226 |
Countries of recruitment | Japan,North America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Zilucoplan Therapeutic category code : 129 Other agents affecting peripheral nervous system Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety confirmatory |
---|---|
Secondary Outcome | efficacy pharmacokinetics pharmacodynamics |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT04225871,2019-001565-33,JapicCTI-205225 |